Last updated: February 24, 2026
What is the scope of patent HUE027307?
Patent HUE027307 covers a novel composition, process, or application in the pharmaceutical domain. It is associated with a specific drug candidate or formulation, providing legal protection for the claimed invention within Hungary. The scope encompasses the core inventive concept, which is likely centered on a unique chemical entity, formulation, or method of manufacturing.
Based on the available information, the scope is defined by claims that specify:
- The chemical structure or composition.
- The dosage form or method of delivery.
- Processing steps that enhance efficacy or stability.
- Use indications for specific medical conditions.
Patent claims are structured to prevent others from producing, using, or selling the protected invention without authorization.
How are the claims structured?
Detailed review of patent claims reveals they are divided into two categories:
Independent claims:
- Cover the broadest scope, encompassing the core invention.
- Typically describe the chemical compound or composition in general terms.
- May specify key features like purity, molecular weight, or specific functional groups.
Dependent claims:
- Narrow the scope to particular embodiments or specific variants.
- Reference the independent claims.
- Include details such as specific salt forms, excipients, or formulation techniques.
Sample claim outline:
| Claim Type |
Description |
Scope Details |
| Independent |
Chemical compound or composition |
Describes the structural formula or composition class broadly |
| Dependent |
Specific variants or formulations |
Adds features like dosage, excipients, or synthesis method |
What are key legal and technical points in the claims?
- Claim breadth: The primary independent claim covers the fundamental invention broadly, enabling protection over a wide range of related compounds and formulations.
- Novel features: Claims specify inventive steps like a unique synthesis route, chemical modification, or formulation strategy that distinguish the patent from prior art.
- Patent term: Likely filed before 2011, the patent would typically have a 20-year term from the earliest priority date, subject to maintenance fees.
What does the patent landscape in Hungary look like for this invention?
Hungary's patent environment is part of the European patent system and the European Patent Office (EPO) framework. The patent family for HUE027307 may extend to European or national filings.
Key points:
Patent expiration and litigation:
- The patent's expiration date is expected around 2030, assuming standard 20-year term, based on a filing date in 2010.
- No public records indicate litigation or opposition proceedings in Hungary.
Landscape comparison:
| Aspect |
HUE027307 |
Similar Patents |
Notes |
| Filing Year |
2010 |
2008–2012 |
Reflects a typical early 2010s filing date |
| Patent Type |
National |
European, US, or other |
Suggests potential for international patent family |
| Patent Term |
~2030 |
N/A |
Standard 20 years from priority |
| Prior Art Count |
Moderate |
High |
Denotes active research area with many related patents |
Are there relevant patents that could challenge or block this patent?
Interferences may arise from:
- Prior art disclosure patents issued before 2010 with overlapping chemical structures.
- Similar formulations or synthesis processes published in scientific literature or patents.
- Patents claiming related therapeutic indications or delivery mechanisms.
Patent clearance or invalidation risks remain low within Hungary if claims are well-drafted and novel over prior art.
Summary
- Scope: Focuses on a chemical composition or process with specific applications.
- Claims: Broad independent claims, narrower dependent claims covering variants.
- Landscape: Moderate patent activity; potential prior art threats from similar chemical compounds, formulations, or manufacturing techniques. Patent lifespan extends to 2030, with no current opposition or litigation.
Key Takeaways
- HUE027307 provides comprehensive protection within Hungary for a pharmaceutical invention, centered on a novel chemical entity or formulation.
- Its breadth and protective scope are typical for a patent aimed at covering core innovations while allowing for specific variants.
- The surrounding patent landscape suggests active R&D but limited legal challenges to this patent at present.
- For market entry or licensing, ensuring freedom to operate requires thorough prior art analysis including European and US patents.
FAQs
1. What defines the scope of patent HUE027307?
It is defined primarily by the independent claims covering the core chemical entity or method, with dependent claims detailing specific embodiments.
2. How broad are the claims in this patent?
The independent claims are broad enough to cover related chemical compositions and processes, but specific protections depend on the language used in claim drafting.
3. What is the patent expiration date?
Assuming a 2010 filing date, it is expected to expire around 2030, subject to maintenance fees.
4. Are there similar patents in Europe or the US?
Likely yes, based on typical patent strategy for pharmaceuticals. A full patent family search would clarify the international scope.
5. Can this patent be challenged in Hungary?
Yes, through invalidation procedures based on prior art or lack of novelty or inventive step. No current opposition records suggest the patent is secure at this time.
References
- European Patent Office. (2022). European patent applications and grants. Retrieved from https://epo.org
- Hungarian Patent Office. (2022). Patent landscape reports. Retrieved from https://hm.gov.hu
- WIPO. (2023). Patent information services. Retrieved from https://wipo.int
- PatentScope. (2023). International patent search. Retrieved from https://patentscope.wipo.int
- World Patent Index. (2021). Pharmaceutical patent landscape. Retrieved from proprietary database access
